Clinical Features and Outcomes Associated with Bronchial Asthma Among COVID-19 Hospitalized Patients.
Miguel Angel DiazNelly Catalan-CaceresThais C BeauperthuyCarlos DomingoEthel IbañezCarmen MorataAlfredo De DiegoPublished in: Journal of asthma and allergy (2022)
The prevalence of asthma in COVID-19 hospitalized patients was 5%, consistent with the asthma prevalence in the general population. The asthmatic patients with the previous prescription of moderate or high doses of ICS and/or coexistence of atrial fibrillation at admission had a higher risk of the severe outcome.
Keyphrases
- lung function
- chronic obstructive pulmonary disease
- coronavirus disease
- sars cov
- allergic rhinitis
- atrial fibrillation
- risk factors
- cystic fibrosis
- emergency department
- early onset
- respiratory syndrome coronavirus
- high intensity
- coronary artery disease
- metabolic syndrome
- venous thromboembolism
- skeletal muscle
- mitral valve
- acute coronary syndrome
- left atrial appendage
- drug induced